TW274565B - - Google Patents

Info

Publication number
TW274565B
TW274565B TW082101170A TW82101170A TW274565B TW 274565 B TW274565 B TW 274565B TW 082101170 A TW082101170 A TW 082101170A TW 82101170 A TW82101170 A TW 82101170A TW 274565 B TW274565 B TW 274565B
Authority
TW
Taiwan
Prior art keywords
acylase
amino acid
ala
native
acid sequence
Prior art date
Application number
TW082101170A
Other languages
English (en)
Original Assignee
Fujisawa Yakusin Kogyo Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Yakusin Kogyo Kk filed Critical Fujisawa Yakusin Kogyo Kk
Application granted granted Critical
Publication of TW274565B publication Critical patent/TW274565B/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P35/00—Preparation of compounds having a 5-thia-1-azabicyclo [4.2.0] octane ring system, e.g. cephalosporin
    • C12P35/02—Preparation of compounds having a 5-thia-1-azabicyclo [4.2.0] octane ring system, e.g. cephalosporin by desacylation of the substituent in the 7 position
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52—Genes encoding for enzymes or proenzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/78—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
    • C12N9/80—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5) acting on amide bonds in linear amides (3.5.1)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Cephalosporin Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
TW082101170A 1992-02-27 1993-02-19 TW274565B (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929204439A GB9204439D0 (en) 1992-02-27 1992-02-27 A new cephalosporin c acylase

Publications (1)

Publication Number Publication Date
TW274565B true TW274565B (zh) 1996-04-21

Family

ID=10711322

Family Applications (1)

Application Number Title Priority Date Filing Date
TW082101170A TW274565B (zh) 1992-02-27 1993-02-19

Country Status (15)

Country Link
US (1) US5336613A (zh)
EP (1) EP0558241B1 (zh)
JP (1) JPH0614777A (zh)
KR (1) KR100276541B1 (zh)
CN (1) CN1062903C (zh)
AT (1) ATE121784T1 (zh)
CA (1) CA2090571A1 (zh)
DE (1) DE69300123T2 (zh)
DK (1) DK0558241T3 (zh)
ES (1) ES2071527T3 (zh)
GB (1) GB9204439D0 (zh)
GR (1) GR3015943T3 (zh)
HU (1) HU220460B1 (zh)
TR (1) TR27016A (zh)
TW (1) TW274565B (zh)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE167520T1 (de) * 1990-04-18 1998-07-15 Gist Brocades Nv Mutierte beta-lactamacylasegene
ZA932809B (en) * 1992-04-24 1994-10-21 Lilly Co Eli Process for preparing cephalosporins.
TW400384B (en) * 1993-11-01 2000-08-01 Fujisawa Pharmaceutical Co A new cephalosporin C acylase
EP0775210B1 (en) * 1994-08-12 2000-02-02 Dsm N.V. Mutated penicillin g acylase genes
CN1065278C (zh) * 1994-08-27 2001-05-02 中国科学院上海植物生理研究所 一步两酶法制造7－氨基头孢烷酸
GB9423212D0 (en) 1994-11-17 1995-01-04 Glaxo Group Ltd Industrial enzymes
US6153429A (en) * 1996-04-05 2000-11-28 Vera Genics Ltd. Cell lines useful for in vitro assay for indentification of carcinogens
US5821049A (en) * 1996-04-05 1998-10-13 Viratest Carcinogen Monitoring, Ltd In vitro assay for identification of carcinogens
HU226348B1 (en) 1996-11-05 2008-09-29 Bristol Myers Squibb Co Mutant penicillin g acylases
KR100530299B1 (ko) * 2003-08-11 2005-11-22 산도즈 게엠베하 변이 세팔로스포린 ｃ 아실라제 및 이를 이용한 7-ａｃａ 제조방법
ITMI20040016A1 (it) * 2004-01-12 2004-04-12 Antibiotics S P A Cefalosporina c acilasi
BRPI0621278A2 (pt) * 2005-12-28 2011-12-06 Dsm Ip Assests Bv acilases mutantes
CN109913436B (zh) * 2017-12-12 2023-05-23 石药集团圣雪葡萄糖有限责任公司 含有一个或几个点突变的头孢菌素c酰化酶突变体及其制备方法
CN112662655B (zh) * 2020-12-29 2022-05-03 山东金城柯瑞化学有限公司 头孢菌素c酰化酶突变体及其制备方法和应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4959314A (en) * 1984-11-09 1990-09-25 Cetus Corporation Cysteine-depleted muteins of biologically active proteins
JPS61152286A (ja) * 1984-12-27 1986-07-10 Asahi Chem Ind Co Ltd セフアロスポリンｃアシラ−ゼ産生遺伝情報を担うｄｎａ断片
US4752585A (en) * 1985-12-17 1988-06-21 Cetus Corporation Oxidation-resistant muteins
US4835260A (en) * 1987-03-20 1989-05-30 Genetics Institute, Inc. Erythropoietin composition
IL87276A (en) 1987-08-03 1995-07-31 Fujisawa Pharmaceutical Co Analog of a tissue plasminogen activator containing the Pringle 2 and protease regions only, DNA encoding it, processes for its preparation, and pharmaceutical preparations containing it
GB9019724D0 (en) * 1990-09-10 1990-10-24 Fujisawa Pharmaceutical Co Cephalosporin c acylase

Also Published As

Publication number Publication date
JPH0614777A (ja) 1994-01-25
ATE121784T1 (de) 1995-05-15
TR27016A (tr) 1994-09-15
DE69300123D1 (de) 1995-06-01
EP0558241A3 (en) 1993-12-01
EP0558241A2 (en) 1993-09-01
DE69300123T2 (de) 1996-03-28
DK0558241T3 (da) 1995-07-03
ES2071527T3 (es) 1995-06-16
HU220460B1 (hu) 2002-02-28
CN1062903C (zh) 2001-03-07
EP0558241B1 (en) 1995-04-26
CN1085252A (zh) 1994-04-13
HU9300557D0 (en) 1993-05-28
KR930017918A (ko) 1993-09-20
GR3015943T3 (en) 1995-07-31
GB9204439D0 (en) 1992-04-15
HUT65664A (en) 1994-07-28
CA2090571A1 (en) 1993-08-28
US5336613A (en) 1994-08-09
KR100276541B1 (ko) 2000-12-15

Similar Documents

Publication Publication Date Title
TW274565B (zh)
DE3478469D1 (en) Maltogenic amylase enzyme product, preparation and use thereof
AU1623792A (en) Nonaqueous liquid automatic dishwashing composition containing enzymes
BG42527A3 (en) Method for preparing human immunic interferon
NZ330060A (en) method of culturing hematopoietic cells in a growth media containing human interleukin-3 mutant fusion protein
GB8527335D0 (en) Fermentation process
HU912906D0 (en) Cephalosporine-c acylase
EP0102216A3 (en) Biosynthesis of unnatural cephalosporins
CA2032963A1 (en) Process for producing 7-aminocephem compound or salts thereof
ES8608580A1 (es) Procedimiento para la obtencion de compuestos de eglina
ES8506799A1 (es) Un procedimiento para preparar un concentrado liquido de alfa-amilasa estable a los acidos y exento de actividades de amiloglucosidasa y transferasa.
IE810114L (en) N-benzyloxycarbonyl-l-aspartic acid
AU4846196A (en) Process for the recovery of cephalexin
IE801762L (en) Insulin-zinc crystals
JPS57171925A (en) Antibiotic compound
ES8606887A1 (es) Un metodo para la produccion microbica de interferon.
CA2172954A1 (en) Enzyme and its use in preparing (s)-pipecolic acid
CA2133345A1 (en) A Method of Limiting the Survival of Genetically Engineered Microorganisms in Their Environment
Stabnikova et al. Self-breeding of neuston forms of bacteria.
IT1269301B (it) Procedimento per la conversione della cefalosporina c in acido glutaril - 7 amminocefalosporanico
TW243453B (en) Cloning and characterization of a cardiac adenylyl cyclase